New Delhi: The changes announced by the United Kingdom, adding India’s Covaxin to the list of approved Covid-19 vaccines for international travellers, will come into effect from November 22.
This means that thousands of travellers from India, who have been inoculated with the Bharat Biotech-manufactured jab, will not have to self-isolate after arrival in Britain.
The UK government has also added China’s Sinovac and Sinopharm in its list of approved vaccines, benefiting fully vaccinated people from the United Arab Emirates and Malaysia too. Around one billion doses of these three Covid-19 vaccines have been delivered worldwide.
The changes were announced earlier this month, after the World Health Organization (WHO) cleared their “emergency-use listing”.
The WHO issued an emergency-use listing for Covaxin on November 3.
The UK began recognising Covishield, the Indian version of the AstraZeneca vaccine, for inbound travel from October 4.